Document is current
Any future updates will be listed below
-
Authors
Defesche, Joep C.
Gidding, Samuel S.
Harada-Shiba, Mariko
Hegele, Robert A.
Santos, Raul D.
Wierzbicki, Anthony S.
- License Information
-
More Information
Article History
First Online: 7 December 2017
Competing interests
: S.S.G. acts as a consultant for RegenXbio. M.H.-S. acts as a consultant for Aegerion, receives research funding from Amgen, Astellas, Sanofi and MSD and has received speaker fees from Amgen, Astellas, Astra Zeneca, Sanofi, Boehringer Ingelheim, Otsuka and Daiichi-Sankyo. R.A.H. acts as a consultant for and is on the advisory board of Acasti, Aegerion, Amgen, Boston Heart Diagnostics, Cerenis, Medpace, Pfizer, Regeneron, Sanofi and Valeant. R.S.D. acts as a consultant for Amgen, Biolab, Boehringer Ingelheim, Eli Lilly, Merck, NovoNordisk, Pfizer and Sanofi/Regeneron and has received speaker fees from Amgen, Astra Zeneca and Sanofi/Regeneron. J.C.D. and A.S.W. declare no competing interests.
